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Summary
A novel mechanism for breaking T cell self tolerance is described . B cells induced to make
autoantibody by immunization ofmice with the non-selfproteinhuman cytochrome c can present
the selfproteinmouse cytochrome c to autoreactive T cells in immunogenic form . This mechanism
of breaking T cell self tolerance could account for the role of foreign antigens in breaking not
only B cell but also T cell self tolerance, leading to sustained autoantibody production in the
absence of the foreign antigen .
Systemic lupus erythematosus (SLE) is a severe autoimmune
disease in which antibody production against selected cel-
lular antigens (1) leads to the generation of soluble immune
complexes that damage the microvasculature (2) . Many of
the autoantibodies in SLE are directed at nucleoprotein com-
plexes, and studies of antibody production in individual pa-
tients have suggested that antibodies directed at different com-
ponents of the same particle are found together in the same
patient (3) . Moreover, in animal models, certain ribonucleo-
proteins elicit autoantibodies that resemble those found in
patient sera (4-6), supporting a role for the autoantigens them-
selves in inducing the autoantibody responses . In addition
to antibodies directed at components of nucleosomes, ribo-
somes, and spliceosomes, antibodies to a number of other
intracellular proteins have been observed (7) . Recently, one
of us (M . J . Mamula) has detected production of autoanti-
bodies to the well-characterized protein human cytochrome
c (cyt c)1 in SLE patient sera (8) . Cyt c is a highly conserved
protein and shares several featurescommon to other nucleo-
protein autoantigens (5) . Anti-cyt c autoantibodies fromSLE
patient sera and animal sera bind selected sites ofevolutionary
divergence on the cyt c molecule.
The clustering of autoantibody specificities in SLE sug-
gests that the central defect in the disease could be the pres-
ence of helperT cells directed at a peptide component ofone
of the proteins in the complex, allowing B cells that bind
any component of the complex to present this peptide to the
autoreactive T cell . The autoreactive CD4 T cell recognizing
the autoantigenic complex of self peptide/self class IIMHC
protein on the antigen-specificB cell would then induce syn-
1 Abbreviations used in thispaper. cyt c, cytochrome c ; PPD, purified protein
derivative.
thesis ofautoantibodies . Sequence analysis ofanti-DNA an-
tibodies in mice has suggested that both antigen and antigen-
specific helper T cells are driving this autoimmune response
(9, 10) . If this synthesis is correct, then the analysis of au-
toreactivity in helper T cells could provide a key to under-
standing autoantibody production in SLE.
Early studies on breaking tolerance used foreign molecules
both to induce and to break tolerance. Weigle's laboratory
(11) showed that tolerance to foreign serum albumins could
be broken by immunization with a related serum albumin,
leading to the production of antibody reacting with both
the immunogen and the tolerogen . Loss of tolerance prob-
ably reflects the ability of foreign (non-sel~ peptides to stimu-
late helper T cells that in turn induce B cells to make anti-
bodies to epitopes shared by both the immunizing and the
tolerated protein. Indeed, Chiller et al . (12) showed that ac-
quired tolerance in helper T cells is much more profound
and sustained than is tolerance in B cells. While this may
serve as a model forhow B cell selftolerance could be broken
by infectious agents through "molecular mimicry" (13), this
mechanism does not explain the generation ofautoimmune
diseases such as SLE, since the T cell epitope recognized in
these experimental models is foreign . Thus, this process cannot
lead to the sustained loss of self tolerance required for the
pathogenesis ofautoimmune disease . Similar considerations
apply to models leading to production of autoantibodies by
immunization with foreign erythrocytes (14-16) .
T cell tolerance is established in one of three ways. First,
developingT cells that recognize ubiquitous selfantigens are
clonally deleted in the thymus (17, 18) . T cells specific for
antigens found only on certain tissue cells and not available
in the thymus appear to be clonally inactivated or anergized
by encountering ligand in the absence of required co-stim-
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exists for dominant suppression of self-reactivity in the pe-
riphery (23). Clearly, clonally deleted T cells cannot be im-
munized by any antigen; however, T cells that are not aner-
gized might be inducible to autoreactivity if antigen is
presented by a "professional" APC capable of delivering a
potent co-stimulatory signal (19, 20, 24). In the present studies,
we have obtained evidence for a mechanism by which immu-
nization with a crossreacting antigen might break not only
B cell but also T cell self tolerance. When B cells are simu-
lated with a foreign antigen to make antibody that also binds
a related self protein, these activated autoreactive B cells can
present the selfproteinin immunogenic form to T cells, leading
to T cell autoreactivity. By this means, not only are autoan-
tibodies produced, but also, autoreactive T cells may be gener-
ated, potentially leading to a sustained autoimmune response.
Materials and Methods
Antigens.
￿
Horse heart cyt c (type VI) and rat heart cyt c (type
XX), which is sequence-identical to mouse cyt c, were purchased
from Sigma Chemical Co. (St. Louis, MO). Human cyt c was a
generous gift of Dr. Morris Reichlin (Oklahoma City, OK).
Animals.
￿
MRL/mpj +/+, A/J, CBA/J, C57BL/10J,B10.BR,
and BALB/cByJ mice were obtained from TheJackson Laboratory
(Bar Harbor, ME). BALRK and B10.A(4R) mice were produced
in our breeding colony. In general, 4-8-wk-old mice were used in
the experiments.
Immunization.
￿
Mice were immunized subcutaneously with a
total of 50 or 1001Ag cyt c emulsified 1:1 in CFA (Difco Laborato-
ries, Detroit, MI) in the base of the tail.
Anti-cytochrome c ELISA.
￿
Solid phase immunoassays (ELISA)
were used to detect the presence of cyt c binding antibodies from
mouse sera (5). Rat cyt c and human cyt c were repurified by cation
exchange chromatography and adsorbed to microtiter plates at a
concentration of20 Rg/ml. Plates were blocked with 1% BSA fol-
lowed by the addition of 10-2 dilutions of mouse serum. Rabbit
anti-mouse IgG-alkaline phosphatase (Southern Biotechnology As-
sociates Inc., Birmingham, AL) followed byp-nitrophenylphosphate
substrate (Sigma Chemical Co.) was used to determine the binding
of antibody. In some assays, serum dilutions were first preincubated
with human or rat cyt c (20 ug/ml) before their addition to the
ELISA as a measure of specificity to the two species of cyt c. As
determined previously, the inhibition assays were performed in the
range of solid phase and solution phase antigen excess.
Proliferation Assays.
￿
10 d after immunization with cyt c in CFA
in the base of the tail, paraortic and inguinal lymph nodes were
collected aseptically and single cell suspensions were prepared by
pressing the nodes between the ends offrosted glass slides. Lymph
node cells (LNCs) were washed and resuspended in Click's EHAA
medium containing 5% FCS. LNCs (5 x 101/well) were cultured
with and without antigen in flat-bottomed 96-well microculture
plates. The plates were incubated at 37°C in a 5% CO2, 95% air
humidified incubator for 3 d. 18 h before harvesting, 1 1ACi of
[3H]thymidine was added to each well in 20 Al of Click's medium.
The cultures were harvested using a semiautomatic cell harvester
(Pharmacia LKB Nuclear Inc., Gaithersburg, MD) and counted
in a liquid scintillation counter (Betaplate; Pharmacia LKB Nu-
clear Inc.). For assessment of proliferation of T cell clones, cells
were tested at a concentration of 2 x 10' cells per well together
with varying numbers of mitomycin C-treated syngeneic spleen
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cells as APC. The cultures were incubated for 48 h and tested as
described above. In some assays, cells were incubated with mAbs
anti-CD4 (GK 1.5), anti-CD8 (53-6.72), anti-I-A'° (10-3.62), or
anti-I-Et (Y-17) before proliferation assays.
Generation of Mouse cyt c-speck T Cell Clones.
￿
Mouse cyt
c-specific T cell clones were derived from LNCs of MRL+/+ mice
immunized with 50 Rg mouse cyt c and 50 pg human cyt c. The
LNCs from primed mice were stimulated with 100 g.g/ml mouse
cyt c and cloned by limiting dilution (0.2 cells/well) after 48 h in
culture. Culture medium contained 2 U/ml of 11,2. Clones were
restimulated for 48 h with 20 Pg mouse cyt c in the presence of
3,000 rad irradiated syngeneic spleen cells (3 x 101/well) and fur-
ther expanded with 1 U/ml of 11,2 and 2% rat Con A superna-
tant-containing medium. The clones were restimulated and ex-
panded weekly in 24-well plates by the same protocol.
Isolation and Transfer ofImmune Cells.
￿
MRL+/+ mice were im-
munized in the base of the tail and intraperitoneally with human
cyt c in CFA, boosted at 2 wk with antigen in IFA, and at 3 wk
with antigen in PBS. At 4 wk, the mice possessed high titer serum
antibodies that boundboth human and mouse cyt c in ELISA. Spleen
and lymph node cells were then removed 3 d after the last boost.
B cell populations were enriched by two treatments of spleen cells
with antiThy-1 antibody (Y19) (25) and complement. The adherent
cells were depleted by panning on tissue culture plates at 37°C
for 1 h. T cells were enriched by anti-Ig columns to remove B cells
as described previously (26). 1.5 x 10' purified B or T cells from
either human cyt c immunized or normal control mice were trans-
ferred by subcutaneous injection in the thighs as previously de-
scribed (27). One group of mice received 100 141 immune serum
from human cyt c-immunized mice. The mice were injected in the
base of the tail with 100 Etl CFA containing 100 pg mouse cyt
c. 8 d later, inguinal lymph nodes were collected and T cell prolifer-
ation was measured. In a second experiment, two groups of mice
were primed with CFA alone or CFA containing 50 hg human
cyt c in the hind foot pad. 7 d later, the draining lymph nodes
were removed, treated with antiThy-1 +/C, followed by adher-
ence to plastic for 1 h. Nonadherent cells were transferred to
recipients that were then primed with mouse cyt c as in the previous
experiments.
Murine T and B Cells Are Tolerant to Marine Cytochrome c.
Cyt c is found in all cells, and mice are tolerant to their own
cyt c. We demonstrated tolerance of T cells by immunizing
mice with the sequence-identical rat cyt c and measuring the
ability of immunized lymph node T cells to proliferate to
rat cyt c (Fig. 1 A). No response was observed, but immuni-
zation did elicit a response to the purified protein derivative
(PPD) component of the Mycobacteria found in CFA. Fur-
thermore, no autoantibodies were detected in the serum of
such immunized mice (Fig. 1 B), showing that both humoral
and cell-mediated immunity to mouse cyt c is absent in normal
mice.
Mice Immunized with Human Cyt c Make Antibody but not
T Cell Responses to Mouse cyt c The failure of mice to make
antibody upon immunization with mouse cyt c couldreflect
tolerance of B cells, helper T cells, or both. To test whether
the B cells of mice are tolerant to mouse cyt c, mice were
immunized with human cyt c, and sera were tested for anti-
bodies specific for human or mouse cyt c (Fig. 1 D). Specificantibodies that bind mouse cyt c were produced in response
to immunization with human cyt c . This autoantibody is
fully crossreactive with human cyt c, implying that T cell
help could be delivered entirely by cells specific for peptides
unique to human cyt c (Fig . 2) . Furthermore, mice immunized
withhuman cyt c have potent T cell responses to human cyt
c, but fail to respond to mouse cyt c, confirming the toler-
ance ofmouse T cells to mouse cyt c (Fig. 1 C) . Thus, these
experiments are analogues of the earlier studies of Weigle
(11) on tolerance to foreign antigens ; humoral responses to
tolerated selfproteins can be induced by a related foreign pro-
tein that can activate effective helper T cells . However, the
autoantibody response cannot be expected to be sustained by
helper T cells once the foreign stimulus is removed, since
autoreactive helper T cells are not induced by this immuni-
zation .
Immunization with both Mouse andHuman cyt c Breaks Toler-
ance to Mouse Cytochrome c When mice are immunized with
human cyt c, the absence of a T cell response to mouse cyt
c could reflect true self-tolerance. Alternatively, there could
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Figure 1 . The cellular and humoral immune re-
sponses ofMRL+/+ mice to cyt c . The proliferative
response of LNCs (4 x 10 5 cells/well) from (A) 100
hg mouse cyt c- and (C) 50 Wg human cyt c-im-
munized mice to in vitro stimulation by human cyt
c (A), mouse cyt c (" ), PPD (" ), or no antigen (-) .
Humoral IgG immune response of (B) mouse cyt c-
and (D) human cyt c-immunized mice to human or
mouse cyt c .
be an insufficient amount ofmouse cyt c available to initiate
a T cell response. To test this, mouse and human cyt c were
mixed in CFA and used to immunize mice. Such mice pro-
duced antibody to human and mouse cyt c (Fig. 2) . How-
ever, in this case, primed T cells responded to both human
and mouse cyt c (Fig. 3) . To examine the specificity of such
cells, lines and clones were prepared by culturing these cells
with mouse cyt c and syngeneic APC . The proliferative re-
sponses of these cells show strict specificity for mouse cyt
c (Fig. 4A) . This species specificity was found in all five in-
dividual clones (data not shown) . The response is inhibitable
by antibodies specific for CD4 and I-Ek (Fig. 4 B), sug-
gesting that the responding cells areCD4 T cells that recog-
nize a peptide of murine cyt c presented by the syngeneic
I-E molecule. This is the exact phenotype ofthe most common
mouse T cells that respond to non-self cyt c (28) . This re-
sponse is observed using four different H-2k strains of mice,
but not congenic H-2a or H-26 mice (data not shown) .
Thus, the response does not requireMRL background genes,
although it may require H-2k . The priming of T cells to re-Figure 2 .
￿
The specificity ofanti-cyt c antibodies from immunized mice.
Sera from MRL+/+ mice immunized with 50 Rg human cyt c with or
without 100 Ag mouse cyt c in CFA were assayed by ELISA for binding
to human cyt c (A) or to mouse cyt c (B) . As a measure of specificity,
sera were preincubated with 20 Ag/ml ofmouse or human cyt c, or BSA
as a control protein before the ELISA .
spond to mouse cyt c requires the presence of a crossreacting
foreign cyt c . Both human and horse cyt c have this activity,
whileOVA, although highly immunogenic forOVAreactive
T cells, does not allow priming to mouse cyt c when these
two antigens are mixed in CFA (data not shown) .
B Cells from Mice Immune to Human cyt c Allow Priming
o,fAutoreactive T Cells with Mouse cyt c. Because priming with
human cyt c breaks B cell but not T cell self tolerance, we
thought that crossreactive B cells might be involved in the
loss of T cell tolerance to mouse cyt c when both are used
for priming. Furthermore, the T cell response to mouse cyt
c lags behind that to human cyt c by ti5 d in these dual-
immunized mice, consistent with a requirement for prior B
cell activation (data not shown) . Antigen-specific, activated
B cells have been shown to be effective APC in a number
ofexperimental systems (24, 27, 29-32) . To determine whether
B cells, their secreted antibody, or T cells primed withhuman
1436
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Figure 3 .
￿
The proliferativeresponse ofLNCs fromMRL+/+ miceim-
munized with both human cyt c and mouse cyt c . LNCs from primed
mice were stimulated in vitro with human (A) or mouse (" ) cyt c or
no antigen (-) . Data presented are means of triplicate wells.
cyt c can adoptively transfer the ability to induce T cell re-
sponses to mouse cyt c, mice were primed with human cyt
c and then killed after bleeding. Recipient mice were injected
with purifiedimmuneB or T cells, with B cells from unim-
munized mice, or with immune serum, and primed with
mouse cyt c . As can be seen in Figs. 5, A andB and 6, lymph
node T cells from the primed recipient mice responded to
mouse cyt c only if the recipient had previously received B
cells from mice immunized withhuman cyt c. Immune serum,
immuneT cells, andB cells fromnonimmune donors would
not transfer the ability to prime T cells with mouse cyt c .
Furthermore, the response of the recipient mice was entirely
specific for mouse cyt c, as no proliferative response ofrecip-
ient mice to human cyt c was observed . Thus, the critical
cell involved in breaking tolerance to self cyt c is the antigen-
specific B cell .
In these experiments, we describe a new mechanism by
which selftolerance inT cells may be broken by crossreacting
immunogens . These studies demonstrate the presence of T
cells specific for mouse cyt c in normal H-2k mice . When
self cyt c is presented on its own, no T or B cell response
is observed . However, when the same antigen is presented
by antigen-specificB cells elicited with a serologically cross-
reactive antigen, T cell priming is achieved . These studies
may explain how sustained, T cell-dependent autoantibody
production can be initiated by crossreactive foreign antigens,
such as molecular mimics on infectious agents.60000-1
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The specificity andMHC
class II restrictionofmousecyt c-specific
clonedT cells. (A)The proliferative re-
sponse of a representative mouse cyt
c-specific T cell clone stimulated by
mouse ("), human(A), and horse (/)
cyt c . (B) The proliferative response of
a mouse cyt c-specific T cell line to
mouse cyt c (50 kg/ml) in the presence
of blocking antibody culture superna-
tants : (") anti-CD4, (O) anti-CD8,
(/) anti-I-At, (0) anti-I-Et.
Figure 5.
￿
Purified B cells (") andT
cells (0)-from mice immunized with
human cyt c, or B cells from normal
mice (O)were adoptively transfierredinto
naive mice (see Materials and Methods) .
Mouse anti-human cyt c serum(A)was
also transferred into recipient mice. The
mice were then immunizedwith 100
/Ag mouse cyt c in CFA . After 8 d, the
LNCs (5 x 105 cells/well) from
primed mice were stimulatedwith var-
ious concentrations of mouse cyt c (A)
or human cyt c (B) . Background cpm
for each group ranged from 2,308 to
3,940 and are subtracted to yield (A)
cpm.a
U
4
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Figure 6 .
￿
PurifiedB cells from mice primed with CFA containing 50
hg human cyt c (filledsymbols) orCFA alone (open symbols) were isolated
7 d after immunization and used for adoptive transfer experiments (see
Materials and Methods) . The mice were then immunized andlymph node
proliferation responses were measured in the presence of various concen-
trations of mouse cyt c (squares) or human cyt c (triangles) .
Antigen-specific B cells are known to be highly effective
at concentrating protein antigens for presentation to CD4
T cells (33, 34) . In vivo, B cells have been implicated in T
cell responses by the failure of B cell-deficient mice to be-
come immunized for a T cell-proliferative response to pro-
tein antigens (30, 31) . Furthermore, KurtJones et al . (27)
have reconstituted such mice with antigen-specificB cells and
have shown that these cells are required for the induction
ofT cell responses. However, it should also be noted that
these statements apply to the T cell-proliferative response,
whereas the priming ofhelper T cells may have different re-
quirements, sinceB cell-deficient mice can be primed to yield
competent helperT cells (35-37) . Whether the autoreactive
T cells we have identified can function as helper T cells in
an antibody response remains to be determined .
The activation ofCD4T cells requires presentation of an
antigen/self MHC class II ligand and also the provision of
a suitable co-stimulatory signal (20, 24) . Resting B cells ap-
parently lack the ability to co-stimulateT cells, but activated
B cells are excellent co-stimulators ofT cell clonal expansion
in many systems (24, 29) . Furthermore, existing data sug-
gest that both signals for T cell activation must be delivered
by the same APC (Liu, Y, and C.A . Janeway, manuscript
submitted for. publication) . Thus, the activation of antigen-
specific B cells may aid in breaking T cell self tolerance by
providing both a high level of stimulatory ligand and a high
level ofcostimulator activity on the same APC . Human cyt
c, being a non-self protein, may have less stringent require-
ments for priming, as it can presumably stimulate a more
extensive repertoire of T cells.
Thus, our data provide a potential mechanism for the
breaking of T cell self tolerance. Clearly, this mechanism
cannot operate if autoreactive T cells are not present in the
mouse, as may occur if effective clonal deletion or complete
anergy exist . Nevertheless, this mechanismmay explain how
an infectious agent that carries epitopes that induce autoan-
tibody production but not an autoreactive T cell response
can lead to autoreactiveT cell priming and the sustained au-
toantibody production typical of SLE and other antibody-
mediated autoimmune diseases .
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